Double-blind Ipragliflozin Add-on Study in Japanese Participants With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control on Sitagliptin (MK-0431J-843)
Clinical trial NCT02577003 · COMPLETED
Trial details
- NCT number
- NCT02577003
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2015-11-09
- Primary completion
- 2016-11-25
- Enrollment
- 143
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.